|
Vaneeva A.S., Ivshina A.V., Filimonova O.G.
Assessment of risk factors for osteoporosis in patients with osteoarthritis
|
№2 / 2024
|
|
M.V. Pchelintsev
Tapentadol is a new drug in an old group. An overview of the use of tapentadol in the treatment of pain in cancer patients
|
№6-7 / 2023
|
|
A.S. Mikhailova
CLINICIAN’S ANALGESIC ARSENAL
|
№s3 / 2018
|
|
Z.A. Zalyalova (1, 2), I.F. Khafizova (1), Z.G. Khayatova (1)
PATHOPHYSIOLOGICAL BASES OF REHABILITATION IN CERVICAL DYSTONY
|
№15 / 2017
|
|
C. Speed, B. Wohlfarth
CURRENT APPROACHES TO THERAPY OF PAIN SYNDROME IN SOFT TISSUE INJURIES
|
№s3-16 / 2016
|
|
I.V. Maev, A.A. Samsonov, A.V. Yashina, A.N. Kazyulin, V.A. Shestakov
NEW OPPORTUNITIES IN TREATMENT OF IRRITABLE BOWEL SYNDROME: EFFECTIVE APPROACH AND CORRECTION OF THE QUALITY OF LIFE
|
№15 / 2016
|
|
S.B. Erofeeva
VIBURСOL - DRUG OF CHOICE FOR THE TREATMENT OF ACUTE INFECTIOUS AND INFLAMMATORY CONDITIONS IN PEDIATRIC PATIENTS
|
№11 / 2016
|
|
M.I. Udovika
FEATURES OF THERAPY OF PRIMARY OSTEOARTHROSIS IN PATIENTS WITH COMORBID DISEASES
|
№16 / 2015
|
|
N.M. Bulanov, P.I. Novikov
POTENTIALS FOR THE USE OF LORNOXICAM IN THE TREATMENT OF OSTEOARTHROSIS
|
№7 / 2015
|
|
Yu.E. Azimova
DIFFERENTIATED THERAPY OF PAIN SYNDROMES
|
№18 / 2014
|
|
S.B. Erofeeva
NON-STEROIDAL ANTI-INFLAMMATORY DRUGS IN PEDIATRIC PATIENTS - EFFICACY AND SAFETY OF COMBINED PREPARATIONS
|
№11 / 2014
|
|
Yu.A. Fominykh, Yu.P.Uspensky
IRRITABLE BOWEL SYNDROME: SIGNIFICANCE OF PROBLEM, CLINICAL AND PATHOGENETIC FEATURES, APPROACH TO THE THERAPY
|
№2 / 2014
|
Русский
